NCT06179511
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06179511
Title Study of AZD9829 in CD123+ Hematological Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | DEU | AUS

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site St Louis Missouri 63110 United States Details
Research Site New York New York 10021 United States Details
Research Site Chapel Hill North Carolina 27514 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Heidelberg 3084 Australia Details
Research Site Melbourne VIC 3000 Australia Details
Research Site Tianjin 300020 China Details
Research Site Frankfurt 60590 Germany Details
Research Site Bologna 40138 Italy Details
Research Site Kashiwa 227-8577 Japan Details
Research Site Osaka 545-8586 Japan Details
Research Site Yoshida-gun 910-1193 Japan Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 05505 South Korea Details
Research Site Barcelona 08035 Spain Details
Research Site Salamanca 37007 Spain Details
Research Site Tainan 704 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Manchester M204BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field